MET
MetLifeMetLife is a life & health insurance name in the financials sector. Over the past year it returned +22.6%, against +6.3% over three months and -2.4% over one. It trades 16.6% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 23.7% is moderate by single-stock standards.
Its worst peak-to-trough decline over the year was -17.5%, and it has traded a median $286M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.36 with the S&P 500 proxy, so it has been moving substantially on its own.
How MET scores on all four profiles
Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 4 others in Life & Health Insurance.
Start a free 7-day trial| 1 day | +2.6% |
| 1 week | +1.1% |
| 1 month | -2.4% |
| 3 months | +6.3% |
| 6 months | +38.3% |
| 1 year | +22.6% |
| 12-1 momentum | +25.5% |
| Volatility (1y, annualized) | 23.7% |
| Max drawdown (1y) | -17.5% |
| Distance vs 200-day average | +16.6% |
| Return per unit of risk | 0.95 |
| Median daily dollar volume | $286M |
Get MET when it shows up in a ranking
Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.
Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.